AHR and Insulin resistance: Since HFD-related gut barrier dysfunction is a source of gut, WAT and liver inflammation, and insulin resistance [57], and AhR exerts beneficial effects on the intactness of the gut epithelial barrier [1], attenuation of epithelial barrier dysfunction caused by Mt-P in this model might contribute to the beneficial effects on insulin sensitivity.